logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

David B Ring

This inventor holds 33 USPTO granted patents and 1 EPO patent, primarily in Cancer Immunotherapy. Top assignees: Chiron Corporation, Cetus Corporation, Creative Biomolecules, Inc.. Active years: 1986-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David B Ring. Retrieved from https://idiyas.com/inventor/david-b-ring

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 87.9


Average Co-Inventor Count = 2.3

ph-index = 18

Forward Citations = 1,294(Granted Patents)


Location History:

  • Redwood City, CA (US) (1986 - 2006)
  • Palo Alto, CA (US) (1998 - 2008)

Company Filing History:

goldMedal21 out of 672 
 
Chiron Corporation
 patents
silverMedal8 out of 212 
 
Cetus Corporation
 patents
bronzeMedal3 out of 72 
 
Creative Biomolecules, Inc.
 patents
4. 2 out of 28 
 
Cetus Oncology Corporation
 patents
5. 1 out of 1 
 
Creative Biomoelcules, Inc.
 patent
6. 1 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
7. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1986-2008

Loading Chart...
Loading Chart...
Areas of Expertise:
Glycogen Synthase Kinase
Biosynthetic Binding Proteins
Monoclonal Antibodies
Cancer Antigens
Immuno-Targeting
Tumor Burden
Anti-Human Breast Cancer
Bispecific Antibodies
Immunotoxins
Nucleic Acids
Assay Kits
Fungal Preparations
33 patents (USPTO):Explore Patents
1. 7425557 - Inhibitors of glycogen synthase kinase 3 (2008-09-16),
2. 7138497 - Biosynthetic binding proteins for immuno-targeting (2006-11-21),
3. 7053097 - Inhibitors of glycogen synthase 3 kinase (2006-05-30),
4. 7045519 - Inhibitors of glycogen synthase kinase 3 (2006-05-16),
5. 7037918 - Inhibitors of glycogen synthase kinase 3 (2006-05-02),
6. 6489344 - Inhibitors of glycogen synthase kinase 3 (2002-12-03),
7. 6479284 - Humanized antibody and uses thereof (2002-11-12),
8. 6417185 - Inhibitors of glycogen synthase kinase 3 (2002-07-09),
9. 6153618 - Inhibitors of glycogen synthase 3 kinase (2000-11-28),
10. 6143873 - Monoclonal anti-multiple drug resistance antibody, methods of production (2000-11-07),
11. 6106833 - Bispecific antibodies, methods of production and use thereof (2000-08-22),
12. 6057117 - Identification and use of selective inhibitors of glycogen synthase (2000-05-02),
13. 6054561 - Antigen-binding sites of antibody molecules specific for cancer antigens (2000-04-25),
14. 5959084 - Bispecific antibodies, methods of production and uses thereof (1999-09-28),
15. 5948647 - Nucleic acids encoding antigen-binding sites specific for cancer antigens (1999-09-07),

Title: The Innovative Journey of David B Ring

Introduction: David B Ring, a distinguished inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: David B Ring holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, David B Ring has worked with leading tech companies, research institutions, and universities, honing his skills and expertise in developing cutting-edge solutions to complex problems.

Collaborations: Throughout his career, David B Ring has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and creativity that has led to the successful development of revolutionary products and technologies.

Conclusion: David B Ring's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor in the tech industry. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…